{"id":"https://openalex.org/W7166317127","doi":"https://doi.org/10.1093/ibd/izag101","title":"Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease","display_name":"Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease","publication_year":2026,"publication_date":"2026-06-25","ids":{"openalex":"https://openalex.org/W7166317127","doi":"https://doi.org/10.1093/ibd/izag101","pmid":"https://pubmed.ncbi.nlm.nih.gov/42364076"},"language":"en","primary_location":{"id":"doi:10.1093/ibd/izag101","doi":"https://doi.org/10.1093/ibd/izag101","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ibd/izag101","pdf_url":null,"source":{"id":"https://openalex.org/S45123234","display_name":"Inflammatory Bowel Diseases","issn_l":"1078-0998","issn":["1078-0998","1536-4844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammatory Bowel Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Mahmud Hussain","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahmud Hussain","raw_affiliation_strings":["Research & Development, Shattuck Labs Inc. , Durham, North Carolina,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Shattuck Labs Inc. , Durham, North Carolina,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029262228","display_name":"Anne Y. Lai","orcid":"https://orcid.org/0000-0001-6744-4077","observed_orcids":["https://orcid.org/0000-0001-6744-4077"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Y Lai","raw_affiliation_strings":["Research & Development, Shattuck Labs Inc. , Durham, North Carolina,"],"raw_orcid":"https://orcid.org/0000-0001-6744-4077","affiliations":[{"raw_affiliation_string":"Research & Development, Shattuck Labs Inc. , Durham, North Carolina,","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Derek Franklin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Derek Franklin","raw_affiliation_strings":["Research & Development, Shattuck Labs Inc. , Durham, North Carolina,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Shattuck Labs Inc. , Durham, North Carolina,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035830185","display_name":"Karen L. Lenz","orcid":"https://orcid.org/0009-0002-0541-3448","observed_orcids":["https://orcid.org/0009-0002-0541-3448"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen Lenz","raw_affiliation_strings":["Research & Development, Shattuck Labs Inc. , Durham, North Carolina,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Shattuck Labs Inc. , Durham, North Carolina,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016340598","display_name":"Arpita Patel","orcid":"https://orcid.org/0000-0003-0195-9590","observed_orcids":["https://orcid.org/0000-0003-0195-9590"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arpita Patel","raw_affiliation_strings":["Research & Development, Shattuck Labs Inc. , Durham, North Carolina,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Shattuck Labs Inc. , Durham, North Carolina,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029248453","display_name":"Noah Joseph Murr","orcid":"https://orcid.org/0000-0002-9192-2021","observed_orcids":["https://orcid.org/0000-0002-9192-2021"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noah Murr","raw_affiliation_strings":["Research & Development, Shattuck Labs Inc. , Durham, North Carolina,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Shattuck Labs Inc. , Durham, North Carolina,","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Harunobu Kato","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harunobu Kato","raw_affiliation_strings":["Research & Development, Shattuck Labs Inc. , Durham, North Carolina,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Shattuck Labs Inc. , Durham, North Carolina,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089307313","display_name":"Lini Pandite","orcid":"https://orcid.org/0009-0005-9194-6348","observed_orcids":["https://orcid.org/0009-0005-9194-6348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lini Pandite","raw_affiliation_strings":["Clinical Research, Shattuck Labs Inc. , Durham, North Carolina,"],"raw_orcid":"https://orcid.org/0009-0005-9194-6348","affiliations":[{"raw_affiliation_string":"Clinical Research, Shattuck Labs Inc. , Durham, North Carolina,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001670202","display_name":"Taylor Houghton Schreiber","orcid":"https://orcid.org/0000-0002-8070-1303","observed_orcids":["https://orcid.org/0000-0002-8070-1303"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Taylor H Schreiber","raw_affiliation_strings":["Research & Development, Shattuck Labs Inc. , Durham, North Carolina,"],"raw_orcid":"https://orcid.org/0000-0002-8070-1303","affiliations":[{"raw_affiliation_string":"Research & Development, Shattuck Labs Inc. , Durham, North Carolina,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063908914","display_name":"Suresh de Silva","orcid":"https://orcid.org/0009-0005-1928-4503","observed_orcids":["https://orcid.org/0009-0005-1928-4503"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suresh de Silva","raw_affiliation_strings":["Research & Development, Shattuck Labs Inc. , Durham, North Carolina,"],"raw_orcid":"https://orcid.org/0009-0005-1928-4503","affiliations":[{"raw_affiliation_string":"Research & Development, Shattuck Labs Inc. , Durham, North Carolina,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3862,"currency":"USD","value_usd":3862},"apc_paid":null,"fwci":3.5769,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.86118886,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"32","issue":"8","first_page":"1439","last_page":"1451"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dr3","display_name":"DR3","score":0.7480000257492065}],"concepts":[{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.7857000231742859},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.6722000241279602},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.6708999872207642},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6661999821662903},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6608999967575073},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.6575999855995178},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.6236000061035156},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.6031000018119812},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5343999862670898},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.5259000062942505},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5120999813079834},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.482699990272522},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.47600001096725464},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4447999894618988},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3603000044822693},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.351500004529953},{"id":"https://openalex.org/C2775855021","wikidata":"https://www.wikidata.org/wiki/Q968436","display_name":"Cytokine receptor","level":3,"score":0.33250001072883606},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.3188999891281128},{"id":"https://openalex.org/C2776156784","wikidata":"https://www.wikidata.org/wiki/Q3491954","display_name":"Humanized mouse","level":3,"score":0.275299996137619},{"id":"https://openalex.org/C187316574","wikidata":"https://www.wikidata.org/wiki/Q423698","display_name":"Interleukin 10","level":3,"score":0.272599995136261},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2662999927997589},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.26179999113082886},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.25949999690055847},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.2590000033378601},{"id":"https://openalex.org/C2775862500","wikidata":"https://www.wikidata.org/wiki/Q2453464","display_name":"Colitis","level":2,"score":0.25870001316070557},{"id":"https://openalex.org/C2779280984","wikidata":"https://www.wikidata.org/wiki/Q1472","display_name":"Crohn's disease","level":3,"score":0.2574999928474426},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.25279998779296875},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2502000033855438}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015212","descriptor_name":"Inflammatory Bowel Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015212","descriptor_name":"Inflammatory Bowel Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D019138","descriptor_name":"Antibodies, Blocking","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D053219","descriptor_name":"Receptors, Tumor Necrosis Factor, Member 25","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053219","descriptor_name":"Receptors, Tumor Necrosis Factor, Member 25","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D053380","descriptor_name":"Tumor Necrosis Factor Ligand Superfamily Member 15","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053380","descriptor_name":"Tumor Necrosis Factor Ligand Superfamily Member 15","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D053380","descriptor_name":"Tumor Necrosis Factor Ligand Superfamily Member 15","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1093/ibd/izag101","doi":"https://doi.org/10.1093/ibd/izag101","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ibd/izag101","pdf_url":null,"source":{"id":"https://openalex.org/S45123234","display_name":"Inflammatory Bowel Diseases","issn_l":"1078-0998","issn":["1078-0998","1536-4844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammatory Bowel Diseases","raw_type":"journal-article"},{"id":"pmid:42364076","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42364076","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammatory bowel diseases","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1578322024","https://openalex.org/W1838836312","https://openalex.org/W2034099558","https://openalex.org/W2045252299","https://openalex.org/W2065350308","https://openalex.org/W2087221993","https://openalex.org/W2104397453","https://openalex.org/W2108975227","https://openalex.org/W2109509381","https://openalex.org/W2124093381","https://openalex.org/W2129438140","https://openalex.org/W2145702878","https://openalex.org/W2150244359","https://openalex.org/W2161890468","https://openalex.org/W2162170222","https://openalex.org/W2166060998","https://openalex.org/W2168647393","https://openalex.org/W2501050146","https://openalex.org/W2607252897","https://openalex.org/W2791351154","https://openalex.org/W2895309623","https://openalex.org/W2918590973","https://openalex.org/W3022302110","https://openalex.org/W3195698974","https://openalex.org/W4200071037","https://openalex.org/W4310239704","https://openalex.org/W4402497785","https://openalex.org/W4402826911","https://openalex.org/W4406705372","https://openalex.org/W4412534301","https://openalex.org/W7160199598"],"related_works":["https://openalex.org/W4408141736","https://openalex.org/W4406705724","https://openalex.org/W2301643837","https://openalex.org/W7125367221","https://openalex.org/W4402497785","https://openalex.org/W2025846005","https://openalex.org/W2918590973","https://openalex.org/W1012441288","https://openalex.org/W2965829044","https://openalex.org/W7125097123"],"abstract_inverted_index":{"BACKGROUND:":[0],"Death":[1],"receptor":[2,10,19,82,229],"3":[3],"(DR3;":[4],"also":[5],"termed":[6],"tumor":[7,21],"necrosis":[8,22],"factor":[9,23],"superfamily":[11],"member":[12],"25":[13],"[TNFRSF25])":[14],"is":[15,29,243],"the":[16,74,99,249,256,261],"sole":[17],"functional":[18],"for":[20],"(TNF)-like":[24],"cytokine":[25,179,199],"1A":[26],"(TL1A)":[27],"and":[28,39,43,71,87,93,115,123,139,149,163,186,201,212,224,259],"constitutively":[30],"expressed":[31],"on":[32],"effector":[33],"lymphoid":[34],"cells":[35,134],"in":[36,40,54,68,130,181],"peripheral":[37,131],"blood":[38,132],"both":[41],"inflamed":[42],"adjacent":[44],"noninflamed":[45],"tissues.":[46],"Excessive":[47],"DR3":[48,79,159,173,228],"signaling":[49,92],"contributes":[50],"to":[51,157,218,226,251,266],"chronic":[52],"inflammation":[53,147],"inflammatory":[55],"bowel":[56],"disease":[57,95],"(IBD).":[58],"While":[59],"clinical":[60,262],"trials":[61],"of":[62,78,102,117,255,264],"anti-TL1A":[63],"antibodies":[64],"have":[65],"demonstrated":[66,221],"efficacy":[67],"ulcerative":[69],"colitis":[70],"Crohn":[72],"disease,":[73],"stable":[75],"expression":[76],"pattern":[77],"suggests":[80],"that":[81,241],"blockade":[83],"may":[84],"more":[85],"effectively":[86],"durably":[88],"inhibit":[89],"TL1A-driven":[90,198],"proinflammatory":[91,178],"limit":[94],"propagation.":[96],"We":[97],"describe":[98],"preclinical":[100],"development":[101,263],"SL-325,":[103],"a":[104,244],"fully":[105],"human,":[106],"Fc-silent,":[107],"high-affinity":[108],"DR3-blocking":[109,246],"monoclonal":[110],"antibody.":[111],"METHODS:":[112],"Binding":[113],"affinity":[114,162],"specificity":[116,165],"SL-325":[118,155,175,196,209,242,265],"were":[119],"evaluated":[120],"using":[121],"biophysical":[122],"cell-based":[124],"assays.":[125],"Functional":[126],"activity":[127],"was":[128,210],"assessed":[129],"mononuclear":[133],"(PBMCs)":[135],"from":[136,183],"healthy":[137,184],"donors":[138,185],"IBD":[140,187],"patients,":[141],"an":[142,190],"ex":[143,191],"vivo":[144,192],"human":[145,158,193],"intestinal":[146,194],"model,":[148,195],"cynomolgus":[150],"macaque":[151],"toxicology":[152],"studies.":[153],"RESULTS:":[154],"bound":[156],"with":[160,248],"picomolar":[161],"high":[164],"while":[166],"potently":[167],"blocking":[168],"TL1A":[169],"binding":[170],"without":[171,232],"inducing":[172],"agonism.":[174],"suppressed":[176],"TL1A-induced":[177],"secretion":[180],"PBMCs":[182],"patients.":[188],"In":[189,206],"inhibited":[197],"production":[200],"preserved":[202],"epithelial":[203],"barrier":[204],"integrity.":[205],"nonhuman":[207],"primates,":[208],"safe":[211],"well":[213],"tolerated":[214],"at":[215],"doses":[216],"up":[217],"100":[219],"mg/kg,":[220],"dose-proportional":[222],"pharmacokinetics,":[223],"led":[225],"prolonged":[227],"occupancy":[230],"(RO)":[231],"immune":[233],"activation":[234],"or":[235],"proliferation.":[236],"CONCLUSION:":[237],"These":[238],"data":[239],"demonstrate":[240],"novel":[245],"antibody":[247],"potential":[250],"provide":[252],"durable":[253],"inhibition":[254],"TL1A/DR3":[257],"axis":[258],"support":[260],"treat":[267],"IBD.":[268]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-06-28T00:00:00"}